Home › Pharma & Clinical News

Live Intelligence 5 Intelligence Reports US FDA & CDSCO Updated Daily

Pharma & Clinical News & Regulatory Intelligence 2026

Breaking pharmaceutical news, clinical trial phase 3 results, US FDA approvals, CDSCO alerts, plant cGMP audit updates, and healthcare industry intelligence.

US FDA Priority Review for Datopotamab Deruxtecan (Dato-DXd) in Breast Cancer: Phase 3 Clinical Endpoints 2026

US FDA Priority Review for Datopotamab Deruxtecan (Dato-DXd) in Breast Cancer: Phase 3 Clinical Endpoints 2026

Pharma Enterprise

Regulatory Notice US FDA / CDSCO Oct 29, 2026

Verified Intelligence

Read Full Report →

US FDA & EMA AI Clinical Trials Guidance: Regulatory Standards for Clinical SAS, CDM & Data Integrity 2026

US FDA & EMA AI Clinical Trials Guidance: Regulatory Standards for Clinical SAS, CDM & Data Integrity 2026

Pharma Enterprise

Regulatory Notice US FDA / CDSCO Oct 29, 2026

Verified Intelligence

Read Full Report →

CDSCO Approves Phase 3 Trials for Indigenous CAR-T Cell Therapy in India: Clinical Endpoints & Safety 2026

CDSCO Approves Phase 3 Trials for Indigenous CAR-T Cell Therapy in India: Clinical Endpoints & Safety 2026

Pharma Enterprise

Regulatory Notice US FDA / CDSCO Oct 29, 2026

Verified Intelligence

Read Full Report →

US FDA Form 483 for Indian Sterile Injectable Plant: Cleanroom Airflow, Media Fill Observations & CAPA 2026

US FDA Form 483 for Indian Sterile Injectable Plant: Cleanroom Airflow, Media Fill Observations & CAPA 2026

Pharma Enterprise

Regulatory Notice US FDA / CDSCO Oct 29, 2026

Verified Intelligence

Read Full Report →

US FDA Approves Linvoseltamab Bispecific Antibody for Multiple Myeloma: Phase 3 Clinical Trial Results 2026

US FDA Approves Linvoseltamab Bispecific Antibody for Multiple Myeloma: Phase 3 Clinical Trial Results 2026

Pharma Enterprise

Regulatory Notice US FDA / CDSCO Oct 29, 2026

Verified Intelligence

Read Full Report →